Acute Myeloid Leukemia: Epidemiology and Etiology

por Deschler, Barbara, Lübbert, Michael
Publicado 2008

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

por Morera, Ludovica, Lübbert, Michael, Jung, Manfred
Publicado 2016

AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms

por Rejeski, Kai, Duque-Afonso, Jesús, Lübbert, Michael
Publicado 2021

Clinical Results of Hypomethylating Agents in AML Treatment

por Cruijsen, Marjan, Lübbert, Michael, Wijermans, Pierre, Huls, Gerwin
Publicado 2014

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

por Wagner, Julia M., Hackanson, Björn, Lübbert, Michael, Jung, Manfred
Publicado 2010

Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report

por Schüller, Hannah, Klein, Franziska, Lübbert, Michael, Prager, Eric Peter
Publicado 2020

Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies

por Stomper, Julia, Rotondo, John Charles, Greve, Gabriele, Lübbert, Michael
Publicado 2021

The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia

por Santini, Valeria, Lübbert, Michael, Wierzbowska, Agnieszka, Ossenkoppele, Gert J.
Publicado 2021

Absence of early platelet increment in healthy mice during decitabine treatment

por Baumann, Juliane, Spindler, Markus, Throm, Yannick, Lübbert, Michael, Bender, Markus
Publicado 2022

Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment

por Elrakaybi, Asmaa, Ruess, Dietrich A., Lübbert, Michael, Quante, Michael, Becker, Heiko
Publicado 2022

The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells

por Greve, Gabriele, Schiffmann, Insa, Pfeifer, Dietmar, Pantic, Milena, Schüler, Julia, Lübbert, Michael
Publicado 2015

The AML-associated K313 mutation enhances C/EBPα activity by leading to C/EBPα overexpression

por Gentle, Ian Edward, Moelter, Isabel, Badr, Mohamed Tarek, Döhner, Konstanze, Lübbert, Michael, Häcker, Georg
Publicado 2021

The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy

por Schröder, Rieke, Illert, Anna-Lena, Erbes, Thalia, Flotho, Christian, Lübbert, Michael, Duque-Afonso, Jesús
Publicado 2021

Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells

por Öz, Simin, Raddatz, Günter, Rius, Maria, Blagitko-Dorfs, Nadja, Lübbert, Michael, Maercker, Christian, Lyko, Frank
Publicado 2014

Deferasirox-induced robust and dose-dependent reversal of anemia in a patient with variants in the TRIB2 and ABCB6 genes

por Stomper, Julia, Richter-Pechanska, Paulina, Pfeifer, Dietmar, Andolfo, Immacolata, Iolascon, Achille, Muckenthaler, Martina U., Lübbert, Michael
Publicado 2022

Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat

por Blagitko-Dorfs, Nadja, Jiang, Yi, Duque-Afonso, Jesús, Hiller, Jan, Yalcin, Arzu, Greve, Gabriele, Abdelkarim, Mahmoud, Hackanson, Björn, Lübbert, Michael
Publicado 2013

DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (V...

por Grishina, Olga, Schmoor, Claudia, Döhner, Konstanze, Hackanson, Björn, Lubrich, Beate, May, Annette M., Cieslik, Caroline, Müller, Michael J., Lübbert, Michael
Publicado 2015

Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics

por Javorniczky, Nora Rebeka, Grishina, Olga, Hund, Inga, Pantic, Milena, Pfeifer, Dietmar, Schmoor, Claudia, Thomas, Johanna, Duyster, Justus, Becker, Heiko, Lübbert, Michael
Publicado 2023

Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis

por Rettig, Andrés R., Ihorst, Gabriele, Bertz, Hartmut, Lübbert, Michael, Marks, Reinhard, Waterhouse, Miguel, Wäsch, Ralph, Zeiser, Robert, Duyster, Justus, Finke, Jürgen
Publicado 2021

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR(+) Acute Lymphoblastic Leukemia

por Mostufi-Zadeh-Haghighi, Gila, Veratti, Pia, Zodel, Kyra, Greve, Gabriele, Waterhouse, Miguel, Zeiser, Robert, Cleary, Michael L., Lübbert, Michael, Duque-Afonso, Jesús
Publicado 2023